Arkolith/Insider Trading/RUBY/Form 4

Appelhans Dannielle

CEO and PresidentRubius Therapeutics, Inc. (RUBY) · full profile →Form 4 · filed Feb 27, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1K
Net Open-Market Flow
-$1K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2023Sell(S)10K$0.13$1K0

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-026139) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML